Rational Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Rational Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,064	Closed	-$354K	–	536
2019 Q3	$354K	Buy	+1,064	New	+$347K	0.14%	178
2019 Q2	–	Sell	-1,139	Closed	-$348K	–	559
2019 Q1	$348K	Buy	+1,139	New	+$307K	0.09%	161
2015 Q2	–	Sell	-10,650	Closed	-$1.44M	–	491
2015 Q1	$1.44M	Sell	10,650 -5,000	-32%	-$620K	0.35%	101
2014 Q4	$1.89M	Buy	+15,650	New	+$1.8M	0.37%	92
2013 Q4	$1.93M	Hold	15,650	–	–	0.17%	200
2013 Q3	$1.84M	Hold	15,650	–	–	0.14%	231
2013 Q2	$1.76M	Buy	+15,650	New	+$1.84M	0.15%	236

Other funds holding BIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rational Advisors's BIO Position: Q4 2019 in Review

Rational Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2019, closing a stake of 1,064 shares — an estimated $354K sold.

Rational Advisors first reported a position in BIO in Q2 2013 and held it in 7 quarters. The position peaked at $1.93M in Q4 2013. 386 funds tracked by Wall St. Rank hold BIO as of Q4 2019.

Rational Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2019 after selling out during the quarter.
Rational Advisors sold 1,064 Bio-Rad Laboratories Class A shares in Q4 2019, an estimated $354K.
Rational Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 7 quarters.
Rational Advisors's Bio-Rad Laboratories Class A position peaked at $1.93M in Q4 2013.
386 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2019.

Based on Rational Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.